Repurposing of conformationally-restricted cyclopentane-based AKT-inhibitors leads to discovery of potential and more selective antileishmanial agents than miltefosine.

MLA

Hassan, Ahmed H. E., et al. “Repurposing of Conformationally-Restricted Cyclopentane-Based AKT-Inhibitors Leads to Discovery of Potential and More Selective Antileishmanial Agents than Miltefosine.” Bioorganic Chemistry, vol. 141, Dec. 2023, p. 106890. EBSCOhost, https://doi.org/10.1016/j.bioorg.2023.106890.

APA

Hassan, A. H. E., Alam, M. M., Phan, T.-N., Baek, K.-H., Lee, H., Cho, S. B., Lee, C. H., Kim, Y. J., No, J. H., & Lee, Y. S. (2023). Repurposing of conformationally-restricted cyclopentane-based AKT-inhibitors leads to discovery of potential and more selective antileishmanial agents than miltefosine. Bioorganic Chemistry, 141, 106890. https://doi.org/10.1016/j.bioorg.2023.106890

Chicago

Hassan, Ahmed H E, Mohammad Maqusood Alam, Trong-Nhat Phan, Kyung-Hwa Baek, Hyeryon Lee, Soo Bin Cho, Chae Hyeon Lee, Yeon Ju Kim, Joo Hwan No, and Yong Sup Lee. 2023. “Repurposing of Conformationally-Restricted Cyclopentane-Based AKT-Inhibitors Leads to Discovery of Potential and More Selective Antileishmanial Agents than Miltefosine.” Bioorganic Chemistry 141 (December): 106890. doi:10.1016/j.bioorg.2023.106890.